Lu S, Furth E E, Blumberg E A, Bing Z
Department of Pathology, VA Medical Center, Louisville, Kentucky, USA.
Transpl Infect Dis. 2009 Apr;11(2):179-82. doi: 10.1111/j.1399-3062.2009.00365.x. Epub 2009 Feb 6.
Cryptococcosis occurs primarily in immunocompromised patients such as organ transplant recipients. Central nervous system and pulmonary infections are documented most frequently; hepatic involvement is rarely reported. We report a case of early hepatic cryptococcosis in a 54-year-old male liver transplant recipient. Two weeks after orthotopic liver transplant, he was readmitted with fever, malaise, diarrhea, and progressive pulmonary infiltrates. On admission, liver-associated enzymes were decreased from those at discharge after transplantation. Blood and bronchoalveolar lavage cultures were positive for Cryptococcus neoformans. Despite treatment with amphotericin B and flucytosine, the patient developed both marked cholestasis and transaminase elevation. A liver biopsy performed 22 days after admission revealed numerous yeast-like organisms in hepatic sinusoids consistent with C. neoformans. Despite treatment, the patient died 55 days after admission and 66 days after transplantation. Our case illustrates hepatic involvement of cryptococcal infection within the first month following transplantation.
隐球菌病主要发生在免疫功能低下的患者中,如器官移植受者。中枢神经系统和肺部感染最为常见;肝脏受累情况很少被报道。我们报告一例54岁男性肝移植受者早期肝隐球菌病的病例。原位肝移植两周后,他因发热、乏力、腹泻和进行性肺部浸润再次入院。入院时,肝脏相关酶较移植后出院时有所下降。血液和支气管肺泡灌洗培养新型隐球菌呈阳性。尽管使用两性霉素B和氟胞嘧啶进行治疗,但患者仍出现明显的胆汁淤积和转氨酶升高。入院22天后进行的肝脏活检显示肝血窦中有大量酵母样生物体,与新型隐球菌相符。尽管进行了治疗,患者在入院55天后和移植66天后死亡。我们的病例说明了移植后第一个月内隐球菌感染累及肝脏的情况。